Brief: Clovis Oncology Announces First Quarter 2022 Operating Results And Provides Update On Clinical Development Programs
04/05/2022 14:42
May 4 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY ANNOUNCES FIRST QUARTER 2022 OPERATING
RESULTS
AND PROVIDES UPDATE ON CLINICAL DEVELOPMENT PROGRAMS
* Q1 LOSS PER SHARE $0.44
* QTRLY GLOBAL NET PRODUCT REVENUES OF $34.2 MILLION VERSUS
$38.1
MILLION
* Q1 EARNINGS PER SHARE VIEW $-0.43, REVENUE VIEW $37.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nBw8XVx29a
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber